Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog
January 30, 2025

[vc_row][vc_column][vc_single_image image="63063" img_size="full" alignment="center" css=""][vc_column_text css=""]NFCR-supported researcher Dr. Rakesh K. Jain of Massachusetts General Hospital Cancer Center continues to make breakthroughs against some of the most difficult-to-treat cancers. In a recent study published in PNAS: Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma,...

, , , ,

by
Blog
October 21, 2024

[vc_row][vc_column][vc_video link="https://youtube.com/shorts/8pyoUSfWCIU?si=2ddQHEroEyNaLRSX" align="center" css=""][vc_column_text css=""]In 2010, University of Maryland Women's Basketball Coach Brenda Frese’s son, Tyler, was diagnosed with childhood leukemia at the age of 2 and began treatment immediately. By December 2013, Tyler completed his final round of chemotherapy and has been cancer-free ever...

, , , ,

by
Blog
April 1, 2024

[vc_row][vc_column][vc_single_image image="60524" img_size="full" alignment="center" onclick="custom_link" link="https://nfcr.donorsupport.co/-/XQATRQSQ"][vc_column_text]In February 2024, NFCR President and CEO Sujuan Ba, Ph.D., participated in the first global OncoThon event co-hosted by Oncoheroes Biosciences, a biotech company dedicated to pediatric cancer and is a recipient of long-term support from NFCR through our AIM-HI...

,

by
Media Coverage
July 21, 2022

[vc_row][vc_column][vc_single_image image="51753" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Effective and safe treatments are needed for medulloblastoma—the most common type of cancerous brain tumor in children—especially for patients whose cancer has spread to the spinal cord. A recent phase I clinical trial led by researchers at Atrium Health Levine...

, , , , ,

by
Blog
June 15, 2022

[vc_row][vc_column][vc_single_image image="50723" img_size="full" alignment="center"][vc_column_text]In February 2022, the Biden Administration announced the reigniting of the Cancer Moonshot program. This ambitious program was launched in 2016 with three key goals:  accelerating scientific discovery in cancer,  fostering greater collaboration, and  improving the sharing of data The 2022 reignition includes...

, , ,

by
Blog
February 10, 2022

[vc_row][vc_column][vc_single_image image="47475" img_size="full" alignment="center"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Cancer is the leading cause of death by disease for children in the United States. Tragically, children with the rare cancer neuroblastoma often succumb to the disease despite aggressive treatment. That is, until exciting new research showed that adding an experimental antibody to...

, ,